Fidelity Investments
TMCI icon

Fidelity Investments’s Treace Medical Concepts TMCI Stock Holding History

Fidelity Investments’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Sell
45,573
-3,127
-6% -$8.6K ﹤0.01% 3713
2026
Q1 		$65.3K Sell
48,700
-53,750
-52% -$107K ﹤0.01% 3993
2025
Q4 		$251K Buy
102,450
+20,663
+25% +$89.7K ﹤0.01% 3332
2025
Q3 		$549K Buy
81,787
+9,860
+14% +$64.4K ﹤0.01% 2998
2025
Q2 		$423K Buy
71,927
+3,676
+5% +$23.9K ﹤0.01% 3022
2025
Q1 		$573K Sell
68,251
-2,900
-4% -$26.1K ﹤0.01% 2857
2024
Q4 		$529K Sell
71,151
-6,984
-9% -$46.7K ﹤0.01% 2905
2024
Q3 		$453K Buy
78,135
+54,353
+229% +$349K ﹤0.01% 2900
2024
Q2 		$158K Buy
23,782
+21,446
+918% +$173K ﹤0.01% 3117
2024
Q1 		$30.5K Buy
2,336
+654
+39% +$8.72K ﹤0.01% 3822
2023
Q4 		$21.4K Buy
1,682
+398
+31% +$4.02K ﹤0.01% 3911
2023
Q3 		$16.8K Buy
1,284
+521
+68% +$9.54K ﹤0.01% 3895
2023
Q2 		$19.5K Buy
763
+10
+1% +$258 ﹤0.01% 3871
2023
Q1 		$19K Buy
753
+171
+29% +$4.01K ﹤0.01% 3860
2022
Q4 		$13.4K Sell
582
-392
-40% -$9.03K ﹤0.01% 3913
2022
Q3 		$22K Buy
974
+174
+22% +$3.37K ﹤0.01% 3814
2022
Q2 		$12K Sell
800
-411,811
-100% -$6.94M ﹤0.01% 4069
2022
Q1 		$7.8M Sell
412,611
-183,089
-31% -$3.56M ﹤0.01% 2219
2021
Q4 		$11.1M Sell
595,700
-12,965
-2% -$268K ﹤0.01% 2073
2021
Q3 		$16.4M Sell
608,665
-6,835
-1% -$188K ﹤0.01% 1934
2021
Q2 		$19.2M Buy
+615,500
New +$19.6M ﹤0.01% 1860

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments's TMCI Position: Q2 2026 in Review

Fidelity Investments reduced its Treace Medical Concepts (TMCI) stake by 6.4% in Q2 2026, selling an estimated $8.6K and leaving 45,573 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

Fidelity Investments first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $19.2M in Q2 2021. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Fidelity Investments held 45,573 shares of Treace Medical Concepts worth $181K as of Q2 2026.
  • Fidelity Investments sold 3,127 Treace Medical Concepts shares in Q2 2026, an estimated $8.6K.
  • Treace Medical Concepts made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3713 holding.
  • Fidelity Investments first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Treace Medical Concepts position peaked at $19.2M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.